Your session is about to expire
← Back to Search
Cancer Diagnostic Device
EsoGuard for Barrett's Esophagus (ESOGUARDBE1 Trial)
N/A
Waitlist Available
Research Sponsored by Lucid Diagnostics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥5 years either of
GERD symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cross-sectional point in time per subject through study completion which is up to approximately 5 weeks
Awards & highlights
ESOGUARDBE1 Trial Summary
This trial will test a new system for detecting Barrett's Esophagus and Esophageal Adenocarcinoma in high-risk individuals.
Eligible Conditions
- Barrett's Esophagus
- Esophageal Cancer
ESOGUARDBE1 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowESOGUARDBE1 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ cross-sectional point in time per subject through study completion which is up to approximately 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cross-sectional point in time per subject through study completion which is up to approximately 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Efficacy
Secondary outcome measures
Secondary Efficacy
Other outcome measures
Safety of EsoCheck device administration
ESOGUARDBE1 Trial Design
1Treatment groups
Experimental Treatment
Group I: EsoCheck vs. EGD with or without biopsiesExperimental Treatment1 Intervention
All subjects will undergo both the EsoCheck (non-invasive esophageal cell sample collection) followed by EGD (with or without biopsies)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EsoGuard
2020
N/A
~150
Find a Location
Who is running the clinical trial?
Lucid Diagnostics, Inc.Lead Sponsor
5 Previous Clinical Trials
1,582 Total Patients Enrolled
Randy Brown, MSStudy DirectorLucid Diagnostics
Michelle McDermottStudy DirectorLucid Diagnostics
1 Previous Clinical Trials
470 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many geographic areas are hosting this trial?
"Twenty-three clinical trial sites are presently seeking participants for this experiment. These locations span from Rockford to Greenville and everywhere in between. If you choose to join the study, it is best to pick a nearby site so that travelling stresses can be minimized."
Answered by AI
Is recruitment for this trial still open?
"This study, initially posted on February 28th 2020 and last modified on August 26th 2022, is not currently recruiting. However, 75 other medical trials are presently open to participants."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger